CRUSH!!MDS - A phase 2 study of SGI-110 in Philadelphia-negative myeloproliferative neoplasms

1 Görünümler
administrator
administrator
07/29/23

Dr. Pinkal Desai Discusses a Clinical Trial of SGI-110 for Patients with Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Chronic Myelomonocytic Leukemia to learn more & participate in a clinical trial visit crushmds.org

  • kategori

Daha fazla göster

0 Yorumlar Göre sırala

Hiçbir yorum bulunamadı

Facebook Yorumları

Bir sonraki